Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | UTHR | SMMT | ||
| Company | Neurocrine Bioscienc | United Therapeutic | Summit Therapeu ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 134.98 | 359.50 | 18.02 | ||
| High | 137.01 | 363.90 | 18.60 | ||
| Low | 134.12 | 357.98 | 17.71 | ||
| Last | 135.42 | 359.58 | 17.87 | ||
| Change | +0.46 | -0.58 | -0.53 | ||
| % Change | +0.34% | -0.16% | -2.88% | ||
| Volume | 2,265,500 | 1,009,400 | 7,099,100 | ||
| 20-Day Average Volume | 1,009,850 | 326,945 | 2,225,100 | ||
| Previous Close | 134.96 | 360.16 | 18.40 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 129.15 | 368.46 | 18.32 | ||
| 20-Day Raw Stochastic | 70.96% | 27.72% | 44.70% | ||
| 20-Day Relative Strength | 64.05% | 45.67% | 46.59% | ||
| Weighted Alpha | +5.06 | +58.67 | +36.82 | ||
| Today's Opinion | 24% Buy | 56% Buy | 24% Buy | ||
| Previous Opinion | 24% Buy | 56% Buy | 56% Buy | ||
| Last Month's Opinion | 40% Sell | 80% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.88% since 12/13/24 | -0.62% since 12/13/24 | +0.22% since 12/13/24 | ||
| Low | 127.35 on 12/16/24 | 350.60 on 12/19/24 | 16.83 on 12/18/24 | ||
| High | 140.00 on 12/18/24 | 383.00 on 12/18/24 | 19.18 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +9.84% since 11/20/24 | -1.30% since 11/20/24 | -4.03% since 11/20/24 | ||
| Low | 122.37 on 11/21/24 | 350.60 on 12/19/24 | 16.52 on 12/03/24 | ||
| High | 140.00 on 12/18/24 | 383.00 on 12/18/24 | 19.54 on 11/26/24 | ||
| 3-Month | |||||
| %Chg | +14.42% since 09/20/24 | +1.86% since 09/20/24 | -26.73% since 09/20/24 | ||
| Low | 110.95 on 10/03/24 | 342.02 on 10/23/24 | 16.52 on 12/03/24 | ||
| High | 140.00 on 12/18/24 | 417.82 on 11/08/24 | 25.50 on 09/23/24 | ||
| 6-Month | |||||
| %Chg | +1.01% since 06/20/24 | +16.38% since 06/20/24 | +129.10% since 06/20/24 | ||
| Low | 110.95 on 10/03/24 | 308.08 on 06/21/24 | 6.78 on 07/03/24 | ||
| High | 157.98 on 08/01/24 | 417.82 on 11/08/24 | 33.89 on 09/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,710,869 | 16,053,449 | 13,178,196 | ||
| Shares Outstanding, K | 101,247 | 44,645 | 737,448 | ||
| Annual Sales | 1,887,100,000 | 2,327,500,000 | 0 | ||
| Annual Net Income | 249,700,000 | 984,800,000 | -614,930,000 | ||
| Last Quarter Sales | 622,100,000 | 748,900,000 | 0 | ||
| Last Quarter Net Income | 129,800,000 | 309,100,000 | -56,250,000 | ||
| 60-Month Beta | 0.34 | 0.54 | -0.92 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.24 on 10/30/24 | 6.39 on 10/30/24 | -0.08 on 10/30/24 | ||
| Latest Earnings Date | 02/05/25 | 10/30/24 | 10/30/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 36.18 | 15.82 | 0.00 | ||